Gene · 6184
Papers1,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,418
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Congenital Disorders of Glycosylation (CDG): State of the Art in 2026. | J Inherit Metab Dis | 2026 | 42813231 | PubTator, text mining | PubMed |
| ITGBL1 and RPN1 Mark a Fibrotic NP Subpopulation with Coupled Integrin Signaling and N-Glycosylation Programs in IVDD. | J Inflamm Res | 2026 | 42733874 | PubTator, text mining | PubMed |
| PSKR: An LRR-RLK, enhances oxidative stress tolerance by modulating ROS-driven stomatal closure. | Plant Sci | 2026 | 42710550 | PubTator, text mining | PubMed |
| RPN1 at the crossroads of glycosylation, tumor immunity, and disulfidptosis. | Front Pharmacol | 2026 | 42698633 | PubTator, text mining | PubMed |
| Optimized post-GWAS analysis identifies therapeutic targets for essential thrombocythemia and polycythemia vera. | Commun Med (Lond) | 2026 | 42277437 | PubTator, text mining | PubMed |
| Integrative single-cell and spatial transcriptomics with machine learning identify a Luminal-inflam malignant program and reveal an RPN1-PERK UPR vulnerability in triple-negative breast cancer. | Sci Rep | 2026 | 42270806 | PubTator, text mining | PubMed |
| A homozygous nonsense variant in the oligosaccharyltransferase complex gene, RPN1, causes a congenital disorder of glycosylation. | HGG Adv | 2026 | 41935956 | PubTator, text mining | PubMed |
| Multi-omics identification of a programmed cell death-related signature and potential target P4HB for bladder cancer based on a 101-combination machine learning and experimental validation. | Clin Exp Med | 2026 | 41925913 | PubTator, text mining | PubMed |
| Structural dynamics of the midnolin-proteasome during ubiquitin-independent substrate turnover. | Nat Commun | 2026 | 41896529 | PubTator, text mining | PubMed |
| The oncogenic role of ecotropic viral integration site 1 in hematological malignancies: mechanisms of activation and leukemogenesis. | Front Immunol | 2026 | 41777888 | PubTator, text mining | PubMed |
| Identification of multigene predictors of prognosis in patients with ovarian cancer. | iScience | 2026 | 41767263 | PubTator, text mining | PubMed |
| The Degradation Pathway of COP9 Signalosome-Cullin-RING Ubiquitin Ligase Complexes via Autophagy. | Biomolecules | 2026 | 41750288 | PubTator, text mining | PubMed |
| Precise Mapping of the Proteasome Interaction Region (PIR) of p62/SQSTM1: Decoupling Condensate Formation from Proteasome Recruitment. | Cells | 2026 | 41744778 | PubTator, text mining | PubMed |
| Mechanistic Role of Disulfidptosis in Type 2 Diabetes Mellitus. | Mol Nutr Food Res | 2026 | 41731552 | PubTator, text mining | PubMed |
| Structures of the 26S proteasome in complex with the Hsp70 co-chaperone Bag1 reveal a mechanism for direct substrate transfer. | Sci Adv | 2026 | 41719407 | PubTator, text mining | PubMed |
| Pichia-CLM: A language model-based codon optimization pipeline for Komagataella phaffii. | Proc Natl Acad Sci U S A | 2026 | 41701818 | PubTator, text mining | PubMed |
| GlycoRNAs: Biological functions and novel antiviral targets. | Virol Sin | 2026 | 41698513 | PubTator, text mining | PubMed |
| Pohsphorylation of MAP4K1 and MAP4K2 by OST1 is required for drought tolerance. | Plant J | 2026 | 41640200 | PubTator, text mining | PubMed |
| Integrative analysis of SEC13: a prognostic predictor and immunotherapeutic target. | Clin Transl Oncol | 2026 | 41627636 | PubTator, text mining | PubMed |
| ABA and ABA signaling mediate Arabidopsis stomatal response to CO2 via H2O2 and NO production. | Plant Sci | 2026 | 41617021 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6184/papers